# EDGAR Filing Document

**Accession Number:** 0001635073
**File Stem:** 0001193125-26-048206
**Filing Date:** 2026-2
**Character Count:** 4119
**Document Hash:** b98c05ad6481c2dcd1dbeab2372ceb67
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-048206.hdr.sgml**: 20260212

**ACCESSION NUMBER**: 0001193125-26-048206

**CONFORMED SUBMISSION TYPE**: 497K

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260212

**DATE AS OF CHANGE**: 20260212

**EFFECTIVENESS DATE**: 20260212

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nushares ETF Trust
- **CENTRAL INDEX KEY:** 0001635073

**ORGANIZATION NAME:**
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** 497K
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-212032
- **FILM NUMBER:** 26624963

**BUSINESS ADDRESS:**
- **STREET 1:** 333 W. WACKER DR.
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606
- **BUSINESS PHONE:** 312-917-8146

**MAIL ADDRESS:**
- **STREET 1:** 333 W. WACKER DR.
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NuShares ETF Trust
- **DATE OF NAME CHANGE:** 20160614

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Nuveen ETF Trust
- **DATE OF NAME CHANGE:** 20150226

## Series and Classes Contracts Data

### Nuveen Dividend Growth ETF (Series ID: S000071941)

| Class ID   | Class Name                 | Ticker Symbol   |
|:---|:---|:---|
| C000227558 | Nuveen Dividend Growth ETF | NDVG            |

**NUVEEN DIVIDEND GROWTH ETF** 

**SUPPLEMENT DATED FEBRUARY 12, 2026** 

**TO THE SUMMARY PROSPECTUS DATED FEBRUARY 28, 2025** 

The following information should be read in conjunction with the Summary Prospectus for the Nuveen Dividend Growth ETF (the "Fund").

At the recommendation of Nuveen Fund Advisors, LLC, the investment adviser to the Fund, the Board of Trustees of Nushares ETF Trust approved the closure and liquidation of the Fund. Therefore, the Fund will cease operations, liquidate its assets, and prepare to distribute proceeds to shareholders of record on or about April 13, 2026 (the "Liquidation Date").

The last day of secondary market trading of Fund shares will be April 6, 2026. The Fund will also cease accepting creation orders after the close of business on that date. Existing shareholders may sell Fund shares through a broker in the standard manner through this date. Customary brokerage charges may apply to such transactions. In addition, Fund shareholders may continue to reinvest dividends and capital gains distributions received from the Fund through this date. The Fund reserves the right to modify the extent to which sales of shares are limited prior to the Fund's liquidation.

From April 6, 2026 through the Liquidation Date, there is no assurance that there will continue to be a market for the Fund's shares. When the Fund commences the liquidation of its portfolio, which is anticipated to occur on or around April 6, 2026, but may occur sooner, the liquidation process will result in the Fund expecting to increase its cash holdings and will likely deviate from its investment objective, strategies, and policies stated in its Prospectus and SAI from this date until the Liquidation Date.

**It is anticipated that any shareholder remaining in the Fund after the last day of trading on April 6, 2026, will have their shares redeemed automatically on or around the Liquidation Date and receive cash through their broker or other financial intermediary thereafter in an amount equal to the net asset value of their shares as calculated on or about the Liquidation Date.** This amount is expected to include any accrued capital gains and dividends. Shareholders remaining in the Fund that receive cash will not be charged any transaction fees by the Fund. However, the net asset value of the Fund on the date of the automatic redemption will reflect the costs of liquidating and closing the Fund. Whether you sell your shares or your shares are automatically redeemed as described, you will generally recognize a capital gain (or loss) equal to the amount you receive for your shares above (or below) your adjusted cost basis in such shares. Please consult your personal tax advisor about the potential tax consequences.

**PLEASE KEEP THIS WITH YOUR SUMMARY PROSPECTUS** 

**FOR FUTURE REFERENCE** 

NGN-NDVG-0226P